[1] 李民,李幼生.脂肪乳剂中鱼油应用的价值[J].肠外与肠内营养,2009,16(1):55-57.
[2] 崔颖,戴琳琳.乌司他丁治疗合并凝血功能障碍的危重症患者临床效果评价[J].现代医学,2015,43(9):1172-1175.
[3] BONE R C.Toward an epidemiology and natural history of SIRS(systemic inflammatory response syndrome)[J].JAMA,1992,268(24):3452-3455.
[4] BRUN-BUISSON C.The epidemiology of the systemic inflammatory response[J].Intensive Care Med,2000,26(Suppl 1):S64-74.
[5] HAO W,WONG OY,LIU X,et al.ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes[J].J Pediatr Surg,2010,45(12):2412-2418.
[6] HASTURK H,KANTARCI A,GOGUET-SURMENIAN E,et al.Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo[J].J Immunol,2007,179(10):7021-7029.
[7] NAKANISHI K,TAKEDA S,SAKAMOTO A,et al.Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction[J].Crit Care Med,2006,34(5):1351-1357.
[8] TSUJINO T,KOMATSU Y,ISAYAMA H,et al.Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography:a randomized,controlled trial[J].Clin Gastroenterol Hepatol,2005,3(4):376-383.
[9] UEKI M,TAIE S,CHUJO K,et al.Urinary trypsin inhibitor reduces inflammatory response in kidney induced by lipopolysaccharide[J].J Biosci Bioeng,2007,104(4):315-320.
[10] 李健球,赖剑波,刘晨凤,等.乌司他丁对脓毒性休克患者肺损伤防治作用的临床研究[J].现代医学,2011,39(1):41-44.
[11] 罗江辉,李文瑶,陶国才.乌司他丁对缺血再灌注大鼠脑保护及其机制研究[J].东南大学学报:医学版,2016,35(2):199-201.
[12] 刘勇,林建东,肖雄箭,等.乌司他丁预处理对脓毒症大鼠肾组织基因表达的影响[J].中国危重病急救医学,2010,22(9):547-550.
[13] HELLER A R,RÖSSLER S,LITZ R J,et al.Omega-3 fatty acids improve the diagnosis-related clinical outcome[J].Crit Care Med,2006,34(4):972-979.
[14] CALDER P C.Use of fish oil in parenteral nutrition:Rationale and reality[J].Proc Nutr Soc,2006,65(3):264-277.
[15] MATHESON P J,HURT R T,MITTEL O F,et al.Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum[J].J Surg Res,2003,110(2):360-370. |